AstraZeneca moves forward with a $360M API plant in Ireland
AstraZeneca’s application for a $360 million manufacturing site in a Dublin suburb is yet to be accepted, but it is making progress.
The facility, which AstraZeneca first announced in 2021, will be built at an Alexion site in the suburb of Blanchardstown and produce APIs for small molecule therapies. Documents submitted to the Fingal County Council’s Planning and Strategic Infrastructure Department give more details about the project.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters